arginine and Epstein-Barr Virus Infections

arginine has been researched along with Epstein-Barr Virus Infections in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's4 (50.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DiNardo, CD; Tsai, DE1
Barth, S; Cassel, C; Deng, W; Fischer, U; Grässer, FA; Gross, H; Hennard, C; Kremmer, E; Leonhardt, H; Mamiani, A; Masouris, I; Moritz, B; Neuenkirchen, N; Noessner, E; Ostareck, D; Ostareck-Lederer, A; Stober-Grässer, U1
Chen, LC; Cheng, CP; Fang, JS; Kieff, E; Liu, CD; Peng, CW; Zhao, B1
Askin, M; Boulad, F; Di Nicola, M; Faller, DV; Fingeroth, J; Gianni, AM; Hermine, O; Horwitz, S; Klein, C; Levy, A; Mentzer, SJ; O'Reilly, R; Perrine, SP; Small, T; Suarez, F1
Faller, DV; Fingeroth, J; Mentzer, SJ; Perrine, SP; Reilly, JJ1
Faller, DV; Mentzer, SJ; Perrine, SP2

Reviews

3 review(s) available for arginine and Epstein-Barr Virus Infections

ArticleYear
Treatment advances in posttransplant lymphoproliferative disease.
    Current opinion in hematology, 2010, Volume: 17, Issue:4

    Topics: Adoptive Transfer; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Arginine; Butyrates; Epstein-Barr Virus Infections; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Immunologic Factors; Lymphoproliferative Disorders; Rituximab; T-Lymphocytes, Cytotoxic

2010
Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.
    Transplant infectious disease : an official journal of the Transplantation Society, 2001, Volume: 3, Issue:3

    Topics: Antineoplastic Agents; Antiviral Agents; Arginine; Butyrates; Drug Therapy, Combination; Epstein-Barr Virus Infections; Ganciclovir; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Humans; Lung Neoplasms; Lung Transplantation; Lymphoproliferative Disorders; Postoperative Complications; Tumor Cells, Cultured; Virus Latency

2001
Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies.
    Current opinion in oncology, 2001, Volume: 13, Issue:5

    Topics: Antineoplastic Agents; Antiviral Agents; Arginine; Butyrates; Clinical Trials as Topic; Combined Modality Therapy; Enzyme Induction; Epstein-Barr Virus Infections; Ganciclovir; Gene Expression Regulation, Neoplastic; Herpesvirus 4, Human; Humans; Lymphoma, Non-Hodgkin; Prognosis; Thymidine Kinase

2001

Trials

1 trial(s) available for arginine and Epstein-Barr Virus Infections

ArticleYear
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.
    Blood, 2007, Mar-15, Volume: 109, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Arginine; Butyrates; Child; Child, Preschool; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Ganciclovir; Humans; Lymphoma; Male; Middle Aged

2007

Other Studies

4 other study(ies) available for arginine and Epstein-Barr Virus Infections

ArticleYear
Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression.
    PloS one, 2012, Volume: 7, Issue:8

    Topics: Antibodies, Monoclonal; Antibody Specificity; Arginine; Cell Line; DNA; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Heterogeneous-Nuclear Ribonucleoprotein K; Humans; Immunoprecipitation; Methylation; Molecular Sequence Data; Multiprotein Complexes; Mutant Proteins; Promoter Regions, Genetic; Protein Binding; Protein Transport; Repetitive Sequences, Amino Acid; snRNP Core Proteins; Transfection; Viral Matrix Proteins; Viral Proteins

2012
Modulation of Epstein-Barr virus nuclear antigen 2-dependent transcription by protein arginine methyltransferase 5.
    Biochemical and biophysical research communications, 2013, Jan-18, Volume: 430, Issue:3

    Topics: Amino Acid Sequence; Arginine; Cell Line, Tumor; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation; Glycine; Herpesvirus 4, Human; Humans; Methylation; Molecular Sequence Data; Promoter Regions, Genetic; Protein Structure, Tertiary; Protein-Arginine N-Methyltransferases; Repetitive Sequences, Amino Acid; Transcription, Genetic; Viral Proteins

2013
Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma.
    Blood cells, molecules & diseases, 1998, Volume: 24, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Apoptosis; Arginine; Aspergillosis; Butyrates; Cyclophosphamide; Doxorubicin; Drug Synergism; Enzyme Induction; Epstein-Barr Virus Infections; Fatal Outcome; Ganciclovir; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Humans; Lung Neoplasms; Lung Transplantation; Necrosis; Postoperative Complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Thymidine Kinase; Tumor Cells, Cultured; Vincristine; Viral Nonstructural Proteins

1998
Bibliography. Current World Literature. Cancer in AIDS.
    Current opinion in oncology, 2001, Volume: 13, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Agents; Antiviral Agents; Arginine; Butyrates; Epstein-Barr Virus Infections; Ganciclovir; Humans; Incidence; Lymphoma, AIDS-Related; Matrix Metalloproteinases; Sarcoma, Kaposi

2001
chemdatabank.com